# Pilot Study of Dapansutrile Capsules in Schnitzler's Syndrome

> **NCT03595371** · PHASE2 · TERMINATED · sponsor: **Olatec Therapeutics LLC** · enrollment: 2 (actual)

## Conditions studied

- Schnitzler Syndrome

## Interventions

- **DRUG:** dapansutrile

## Key facts

- **NCT ID:** NCT03595371
- **Lead sponsor:** Olatec Therapeutics LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-05-15
- **Primary completion:** 2018-05-29
- **Final completion:** 2018-05-29
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** The study was terminated due to study design issues that did not allow for determination of efficacy and safety in subjects with Schnitzler Syndrome who are currently well controlled on anakinra therapy.
- **Last updated:** 2024-02-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03595371

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03595371, "Pilot Study of Dapansutrile Capsules in Schnitzler's Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03595371. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*